News » MHRA alert » Recall: atomoxetine hard capsules
July 30th 2024
Glenmark Pharmaceuticals Europe Ltd is recalling various batches of various strengths of atomoxetine hard capsules after retesting showed out of specification results.
The affected strengths are 10mg,18mg, 25mg, 40mg, 60mg, 80mg, 100mg and various batches. These are being recalled as a precautionary measure.
Healthcare professionals are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Patients should continue to take medicines from these batches as prescribed
For medical information enquiries please use the following options by phone +44 08004 580 383 or email medical_information@glenmarkpharma.com
For stock control enquiries please email orders.uk@glenmarkpharma.com